Harel Insurance Investments & Financial Services Ltd. Tandem Diabetes Care Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$19.33 - $36.22 $38 - $72	2 New	2 $0
Q4 2020 Jan 26, 2021	SELL	$86.4 - $121.75 $112,320 - $158,275	-1,300 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$95.43 - $116.09 $124,059 - $150,917	1,300 New	1,300 $148,000

Others Institutions Holding TNDM

# of Institutions

359

Shares Held

72.2M

Call Options Held

3.36M

Put Options Held

229K

Black Rock Inc. New York, NY

11.1M
Shares

$410 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.36M
Shares

$271 Million
0.01% of portfolio
Capital World Investors Los Angeles, CA

3.27M
Shares

$120 Million
0.02% of portfolio
State Street Corp Boston, MA

2.66M
Shares

$97.8 Million
0.0% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

2.39M
Shares

$87.9 Million
1.44% of portfolio

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account